Interim results from HCV sprint-1: RVR/EVR from phase 2 study of boceprevir plus pegintrontm (peginterferon alfa-2b)/ribavirin in treatmentnaive subjects with genotype-1 CHC

被引：30

作者：

Kwo, P. ^{[1
]}

Lawitz, E. ^{[2
]}

McCone, J. ^{[3
]}

Schiff, E. ^{[4
]}

Vierling, J. ^{[5
]}

Pound, D. ^{[6
]}

Davis, M. ^{[7
]}

Galati, J. ^{[8
]}

Gordon, S. ^{[9
]}

Ravendhran, N. ^{[10
]}

Rossaro, L. ^{[11
]}

Anderson, E. ^{[12
]}

Jacobson, I. ^{[13
]}

Rubin, R. ^{[14
]}

Mukhopadhyay, P. ^{[15
]}

Chaudhri, E. ^{[15
]}

Pedicone, L. ^{[15
]}

Albrecht, J. ^{[15
]}

机构：

[1] Indiana Univ, Sch Med, Indianapolis, IN USA

[2] Alamo Med Res, San Antonio, TX USA

[3] Mt Vernon Endoscopy Ctr, Alexandria, VA USA

[4] Univ Miami, Ctr Liver Dis, Miami, FL USA

[5] Baylor Coll Med, Houston, TX 77030 USA

[6] Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA

[7] S Florida Ctr Gastroenterol, Wellington, FL USA

[8] Liver Specialist Texas, Houston, TX USA

[9] Henry Ford Hosp, Detroit, MI 48202 USA

[10] Digest Dis Associates, Baltimore, MD USA

[11] Univ Calif Davis, Sacramento, CA 95817 USA

[12] Liver & Intestinal Res Ctr, Vancouver, BC, Canada

[13] Cornell Univ, Weill Med Coll, New York, NY 10021 USA

[14] Digest Healthcare Georgia, Atlanta, GA USA

[15] Schering Plough Res Inst, Kenilworth, NJ USA

来源：

JOURNAL OF HEPATOLOGY | 2008年 / 48卷

关键词：

D O I：

10.1016/S0168-8278(08)60997-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

995

引用

页码：S372 / S372

页数：1